Literature DB >> 12878098

Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.

Pedram Sendi1, Maiwenn J Al.   

Abstract

The classical decision rule of cost-effectiveness analysis uses a threshold cost-effectiveness ratio as a cut-off point for resources allocation. One assumption of this decision rule is complete divisibility of health care programs. In this article, we argue that health care programs cannot be completely divisible since individuals are not divisible. Consequently, instead of a linear programming approach, an integer programming approach to budget allocation is suggested. The integer programming framework can be extended to include uncertainty in the analysis. An objective function (expected aggregate effects) is maximised subject to the constraint that the probability of exceeding the budget is limited to an arbitrary level (e.g., 0.05). In case the budget is exceeded, the objective function is penalised in order to account for the opportunity costs of the additional resource requirements.

Mesh:

Year:  2003        PMID: 12878098     DOI: 10.1016/s0277-9536(02)00477-x

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  The HAART side of resource allocation.

Authors:  Pedram Sendi; Amiram Gafni
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

2.  A risk-adjusted approach to comparing the return on investment in health care programs.

Authors:  Pedram Sendi; Maiwenn J Al; Heinz Zimmermann
Journal:  Int J Health Care Finance Econ       Date:  2004-09

3.  Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy.

Authors:  Pedram Sendi
Journal:  Int J Health Care Finance Econ       Date:  2008-03-20

4.  Incentives for Optimal Multi-level Allocation of HIV Prevention Resources.

Authors:  Monali M Malvankar; Gregory S Zaric
Journal:  INFOR       Date:  2011-11-01       Impact factor: 1.588

5.  Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine.

Authors:  Stuart J Wright; Mike Paulden; Katherine Payne
Journal:  Med Decis Making       Date:  2020-10       Impact factor: 2.583

6.  Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve.

Authors:  Pedram Sendi
Journal:  Pharmacoeconomics       Date:  2020-10-31       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.